Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

SARS-CoV-2 infection in patients with systemic autoimmune diseases
Pilar Brito‐Zerón, Antoni Sisó‐Almirall, Alejandra Flores-Chávez, et al.
Clinical and Experimental Rheumatology (2021) Vol. 39, Iss. 3, pp. 676-687
Open Access | Times Cited: 31

Showing 1-25 of 31 citing articles:

BNT162b2 mRNA COVID-19 vaccine and booster in patients with autoimmune rheumatic diseases: a national cohort study
Amir Bieber, Iftach Sagy, Lena Novack, et al.
Annals of the Rheumatic Diseases (2022) Vol. 81, Iss. 7, pp. 1028-1035
Open Access | Times Cited: 34
A comprehensive review of COVID-19 symptoms and treatments in the setting of autoimmune diseases
Zahra Hamidi, Shaghaiegh Jabraeili-Siahroud, Yalda Taati-Alamdari, et al.
Virology Journal (2023) Vol. 20, Iss. 1
Open Access | Times Cited: 20
SARS‐CoV‐2 Entry Factors ACE2, TMPRSS2 and FURIN in Salivary Glands From Primary Sjögren's Disease
Fernanda Aragão Felix, Flávia Martins Vasconcelos Filiú, Tarcı́lia Aparecida Silva, et al.
Journal of Oral Pathology and Medicine (2025)
Closed Access
Impact of Distinct Therapies on Antibody Response to SARS‐CoV‐2 Vaccine in Systemic Lupus Erythematosus
Emily Figueiredo Neves Yuki, Eduardo Ferreira Borba, Sandra Gofinet Pasoto, et al.
Arthritis Care & Research (2021) Vol. 74, Iss. 4, pp. 562-571
Open Access | Times Cited: 31
Severity and mortality of COVID-19 in patients with systemic sclerosis: a Brazilian multicenter study
Sandra Maximiano de Oliveira, Lucas Victória de Oliveira Martins, Ana Paula Lupino-Assad, et al.
Seminars in Arthritis and Rheumatism (2022) Vol. 55, pp. 151987-151987
Open Access | Times Cited: 20
Post-COVID-19 syndrome in patients with primary Sjögren's syndrome after acute SARS-CoV-2 infection
Pilar Brito‐Zerón, Nihan Acar‐Denizli, Vasco C. Romão, et al.
Clinical and Experimental Rheumatology (2021) Vol. 39, Iss. 6, pp. 57-65
Open Access | Times Cited: 24
Characterization and Outcomes of SARS-CoV-2 Infection in Patients with Sarcoidosis
Pilar Brito‐Zerón, Borja Gracia-Tello, Ángel Robles‐Marhuenda, et al.
Viruses (2021) Vol. 13, Iss. 6, pp. 1000-1000
Open Access | Times Cited: 21
COVID-19 severity and vaccine breakthrough infections in idiopathic inflammatory myopathies, other systemic autoimmune and inflammatory diseases, and healthy controls: a multicenter cross-sectional study from the COVID-19 Vaccination in Autoimmune Diseases (COVAD) survey
Leonardo Santos Hoff, R Naveen, Samuel Katsuyuki Shinjo, et al.
Rheumatology International (2022) Vol. 43, Iss. 1, pp. 47-58
Open Access | Times Cited: 15
Inactivated SARS-CoV-2 vaccine in primary Sjögren’s syndrome: humoral response, safety, and effects on disease activity
Sandra Gofinet Pasoto, Ari Stiel Radu Halpern, Lissiane Karine Noronha Guedes, et al.
Clinical Rheumatology (2022) Vol. 41, Iss. 7, pp. 2079-2089
Open Access | Times Cited: 12
From COVID-19 to Sarcoidosis: How Similar Are These Two Diseases?
Min Zhao, Chang Fu Tian, Shan Cong, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 11
Systemic Autoimmune Diseases in Patients Hospitalized with COVID-19 in Spain: A Nation-Wide Registry Study
Víctor Moreno‐Torres, Carmen de Mendoza, Susana Mellor‐Pita, et al.
Viruses (2022) Vol. 14, Iss. 8, pp. 1631-1631
Open Access | Times Cited: 11
Effectiveness and Safety of the COVID-19 Vaccine in Patients With Rheumatoid Arthritis in a Real-World Setting
María Torres-Rufas, Esther F. Vicente‐Rabaneda, Laura Cardeñoso, et al.
(2024)
Open Access | Times Cited: 1
Challenges to Vaccination against SARS-CoV-2 in Patients with Immune-Mediated Diseases
Giuseppe A. Ramirez, Chiara Asperti, Valentina Cucca, et al.
Vaccines (2021) Vol. 9, Iss. 10, pp. 1147-1147
Open Access | Times Cited: 10
Determinants of COVID-19 Disease Severity–Lessons from Primary and Secondary Immune Disorders including Cancer
Antonio Giovanni Solimando, Max Bittrich, Endrit Shahini, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 10, pp. 8746-8746
Open Access | Times Cited: 3
Clinical features and outcomes of COVID-19 in patients with IgG4-related disease: a European multi-centre study
Giuseppe A. Ramirez, Marco Lanzillotta, Mikaël Ebbo, et al.
Lara D. Veeken (2021) Vol. 61, Iss. 5, pp. e109-e111
Open Access | Times Cited: 7
Post covid syndrome and rheumatic diseases: focus on rheumatoid arthritis (own data)
E. S. Aronova, Б. С. Белов, Г. И. Гриднева
Meditsinskiy sovet = Medical Council (2022), Iss. 2, pp. 108-113
Open Access | Times Cited: 5
Coronavirus disease 2019 (COVID-19) in pediatric patients with autoimmune disorders
Parniyan Sadeghi, Parmida Sadat Pezeshki, Nima Rezaei
European Journal of Pediatrics (2023) Vol. 182, Iss. 7, pp. 2967-2988
Open Access | Times Cited: 2
Ocular Behçet disease and COVID-19
Massimo Accorinti, Priscilla Manni, Lorenzo Sampalmieri, et al.
European Journal of Ophthalmology (2022) Vol. 32, Iss. 2, pp. NP148-NP149
Open Access | Times Cited: 4
Influence of vaccination and immunosuppressive treatments on the coronavirus disease 2019 outcomes in patients with systemic autoimmune diseases
Jorge Álvarez Troncoso, Lucía López-Caballero, Ángel Robles-Marhuend, et al.
European Journal of Internal Medicine (2022) Vol. 108, pp. 114-116
Open Access | Times Cited: 4
Effectiveness and Safety of the COVID-19 Vaccine in Patients with Rheumatoid Arthritis in a Real-World Setting
María Torres-Rufas, Esther F. Vicente‐Rabaneda, Laura Cardeñoso, et al.
Vaccines (2024) Vol. 12, Iss. 6, pp. 672-672
Open Access
Characteristics of the new coronavirus infection (COVID-19) in patients with systemic sclerosis
M. Starovoytova, O. Desinova, L. P. Ananyeva, et al.
Modern Rheumatology Journal (2024) Vol. 18, Iss. 6, pp. 73-78
Open Access
Bioinformatics Approaches to Identify the Comorbidity Complexities of SARS-CoV-2 Infection with Crohns Disease
Yue Li, Xiao Han
Journal of College of Physicians And Surgeons Pakistan (2023), pp. 1093-1099
Open Access | Times Cited: 1
COVID-19 clinical spectrum in psoriatic arthritis patients on biologics and tsDMARDs: results from a cohort at an Italian epicentre of the pandemic's third wave
Marco Tasso, Erika Mostacciuolo, Valentina Ugoccioni, et al.
Clinical and Experimental Rheumatology (2021)
Open Access | Times Cited: 2
Understanding the Attitudes and Willingness of Adult Chinese Patients with Rheumatic Diseases Towards COVID-19 Vaccination
Huiqiong Zeng, Hanjiang Liu, Meifen Liu, et al.
Risk Management and Healthcare Policy (2022) Vol. Volume 15, pp. 2269-2281
Open Access | Times Cited: 1
Rheumatoid arthritis, multiple sclerosis and lupus: key points from the COVID-19 era
J. M. Silva, Fátima Silva, Sandra Clara Soares
International Journal of Research in Medical Sciences (2023) Vol. 11, Iss. 6, pp. 2214-2236
Open Access
Page 1 - Next Page

Scroll to top